Intertriginous infections in adults receiving antileukemia chemotherapy.
Because intertriginous infections in patients receiving antileukemia chemotherapy may be life-threatening, all sites where skin contacts skin should be thoroughly examined daily. Early detection and immediate medical intervention designed to confine and cure the infection before it progresses to blood-borne dissemination of the infecting organisms are essential in these immunosuppressed patients.
Dreizen
S
S
Department of Oral Oncology, University of Texas Health Science Center, Houston 77225.
McCredie
K B
KB
Keating
M J
MJ
Bodey
G P
GP
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001004:Anus Diseases / Q000150:complications / Q000473:pathology; D001365:Axilla; D006119:Groin; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007938:Leukemia / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D010502:Perineum; D012874:Skin Diseases, Infectious / Q000150:complications / Q000473:pathology* / Q000628:therapy
D000970:Antineoplastic Agents